Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TYO/4519 stock hub

TYO/4519 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4519is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13T

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4519

In the news

Latest news · TYO/4519

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.3

P25 12.7P50 15.8P75 21.7

Trailing P/E28.8

P25 11.7P50 15.2P75 22.3

ROE23.7

P25 -1.6P50 7.1P75 11.9

ROIC41.8

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4519 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

JPY

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	5,104
Employees Change	78%
Employees Change Percent	1.55
Enterprise value	JPY 12.2T
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	JP3519400000
Last refreshed	2026-05-10
Market cap	JPY 13T
Price	JPY 7,900
Price currency	JPY
Rev Per Employee	252,983,738.24x
Sector	Healthcare
Sic	2834
Symbol	tyo/4519
Website	https://www.chugai-pharm.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.48%
EV Earnings	26.87x
EV/EBIT	19.85x
EV/EBITDA	18.84x
EV/FCF	32.42x
EV/Sales	9.41x
FCF yield	2.88%
Forward P/E	25.34x
P/B ratio	6.82x
P/E ratio	28.75x
P/S ratio	10.07x
PE Ratio10 Y	31.36x
PE Ratio3 Y	27.74x
PE Ratio5 Y	24.54x
PEG ratio	1.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.42%
EBITDA Margin	49.48%
FCF margin	29.02%
Gross margin	71.45%
Gross Profit	JPY 922.6B
Gross Profit Growth	6.31%
Gross Profit Growth Q	14.12%
Gross Profit Growth3 Y	9.72%
Gross Profit Growth5 Y	12.64%
Net Income	JPY 452.2B
Net Income Growth	10.25%
Net Income Growth Q	18.7%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	12.67%
Net Income Growth5 Y	16.51%
Pretax Margin	48.18%
Profit Margin	35.02%
Profit Per Employee	JPY 88.6M
Profitable Years	23
ROA	17.38
Roa5y	17.07
ROCE	31.6
ROE	23.71
Roe5y	24.4
ROIC	41.79
Roic5y	42.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.74%
Cagr15y	23.42%
Cagr1y	-3.74%
Cagr20y	13.99%
Cagr3y	32.71%
Cagr5y	16.39%
Div CAGR10	27.12%
Div CAGR3	38.6%
Div CAGR5	28.84%
EPS Growth	10.25
EPS Growth Q	18.7
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	12.66
EPS Growth5 Y	16.5
FCF Growth	6.23%
FCF Growth Q	145.3%
FCF Growth3 Y	15.44%
FCF Growth5 Y	16.9%
OCF Growth	6.84%
OCF Growth Q	83.03%
OCF Growth10 Y	24.36%
OCF Growth3 Y	13.84%
OCF Growth5 Y	12.36%
Revenue Growth	5.66x
Revenue Growth Q	11.54x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	2.14x
Revenue Growth5 Y	10.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 0.59
Assets	JPY 2.3T
Cash	JPY 850.1B
Current Assets	JPY 1.5T
Current Liabilities	JPY 327.7B
Equity	JPY 1.9T
Interest Coverage	2,957.7
Liabilities	JPY 357.4B
Long Term Assets	JPY 725.7B
Long Term Liabilities	JPY 29.7B
Net Cash	JPY 850.1B
Net Cash By Market Cap	JPY 6.54
Net Cash Growth	-10%
Net Debt EBITDA	JPY -1.33
Net Debt Equity	JPY -0.45
Net Debt FCF	JPY -2.27
Tangible Book Value	JPY 1.8T
Tangible Book Value Per Share	JPY 1,124
WACC	7.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.7
Inventory Turnover	1.41
Net Working Capital	JPY 361.6B
Quick ratio	3.67
Working Capital	JPY 1.2T
Working Capital Turnover	JPY 1.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	17.03%
Dividend Growth Years	4%
Dividend per share	JPY 132
Dividend Years	35
Dividend Yield	1.67%
Ex Div Date	2026-06-29
Last Dividend	JPY 66
Payout Frequency	Semi-Annual
Payout Ratio	99.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	676.01%
1Y total return	-3.74%
200-day SMA	7,913.6
3Y total return	133.77%
50-day SMA	8,957.3
50-day SMA vs 200-day SMA	50over200
5Y total return	113.59%
All Time High	10,700
All Time High Change	-26.17%
All Time High Date	2026-02-25
All Time Low	122.7
All Time Low Change	6,337.73%
All Time Low Date	1997-12-12
ATR	426.3
Beta	0.56
Beta1y	0.36
Beta2y	0.96
Ch YTD	-4.16
High	8,248
High52	10,700
High52 Date	2026-02-25
High52ch	-26.17%
Low	7,865
Low52	5,942
Low52 Date	2025-08-08
Low52ch	32.95%
Ma50ch	-11.8%
Price vs 200-day SMA	-0.17%
RSI	40.5
RSI Monthly	53.9
RSI Weekly	44.54
Sharpe ratio	0.09x
Sortino ratio	0.24
Total Return	1.67%
Tr YTD	-4.16
Tr15y	2,249.65%
Tr1m	-9.6%
Tr1w	-4.18%
Tr3m	-8.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY 612.2B
Operating Income Growth	5.78
Operating Income Growth Q	16.18
Operating Income Growth3 Y	11.25
Operating Income Growth5 Y	15.9
Operating margin	47.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	639,882,056%
Net Borrowing	-8,655,000,000
Shares Insiders	0.01%
Shares Institutions	19.04%
Shares Out	1,645,763,056
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	JPY 374.3B
Average Volume	3,676,330x
Bv Per Share	1,159.2
CAPEX	JPY -66.9B
Ch10y	552.9
Ch15y	1,674
Ch1m	-9.6
Ch1w	-4.18
Ch1y	-6.73
Ch20y	840.5
Ch3m	-8.22
Ch3y	119.3
Ch5y	92.21
Ch6m	5.79
Change	-2.41%
Change From Open	-4.18
Close	8,095
Days Gap	1.85
Depreciation Amortization	26,636,000,000
Dollar Volume	33,402,780,000
Earnings Date	2026-04-24
EBIT	JPY 612.2B
EBITDA	JPY 638.9B
EPS	JPY 275
F Score	4
FCF	JPY 374.8B
FCF EV Yield	3.08x
FCF Per Share	JPY 228
Financing CF	-457,092,000,000
Fiscal Year End	December
Founded	1,925
Graham Number	2676.9734
Graham Upside	-66.11
Income Tax	JPY 170B
Investing CF	-591,000,000
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2020-06-29
Last Split Type	Forward
Lynch Fair Value	JPY 4,537
Lynch Upside	-42.57
Ma150	8,303
Ma150ch	-4.85%
Ma20	8,479.2
Ma20ch	-6.83%
Net CF	-5,435,000,000
Next Earnings Date	2026-07-24
Open	8,245
P FCF Ratio	34.69
P OCF Ratio	29.44
Payment Date	2026-08-28
Position In Range	9.14
Ppne	481,679,000,000
Price Date	2026-05-08
Price EBITDA	JPY 20.35
Ptbv Ratio	7.03
Relative Volume	1.19x
Revenue	1,291,229,000,000x
SBC By Revenue	0.04x
Share Based Comp	483,000,000
Tax By Revenue	13.16x
Tax Rate	27.32%
Tr20y	1,272.85%
Tr6m	7.38%
Volume	4,228,200
Z Score	24.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/4519 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$132 annual per share

Payout ratio

+99.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+28.8%

4 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-06-29

Performance

TYO/4519 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4519?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

TYO/4519 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.5

Neutral momentum band

Price vs 200-day MA

-0.2%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4519

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4519 stock rating?

tyo/4519 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4519 analysis?

The full report lives at /stocks/tyo/4519/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4519?

The latest report frames tyo/4519 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4519 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.